[Clinical evaluation of N-acetylaspartylglutamic acid eyedrops in subacute and chronic atopic conjunctivitis].
Patients with subacute and chronic atopic conjunctivitis who were treated for at least one year with topically applied 2% sodium cromoglycate 4 times daily were switched to N.A.A.G.A. 6% eye drops for 2 months. A statistically significant gain in treatment effect as assessed objectively (+12.25%) and subjectively (+25.90%) was obtained. This effect could be the result of a more effective antiallergic action of N.A.A.G.A. or could be related to a relative tachyphylaxis to sodium cromoglycate.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002908:Chronic Disease; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000627:therapeutic use; D004151:Dipeptides / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions
D004151:Dipeptides; D009883:Ophthalmic Solutions; C027172:isospaglumic acid; D004205:Cromolyn Sodium
Klinische Erprobung von N-acetyl-aspartyl-Glutaminsäure Augentropfen bei subakuter und chronischer atopischer Konjunktivitis.